CD38-077

N/A

Report date: 2025/01/26 19:36:29

Base Information

Drug NameCD38-077

Drug Alias NameAnti-CD38 antibody-drug conjugate (Concortis Biotherapeutics)Duostatin 5.2 + STI-6129 ADC (Concortis Biotherapeutics)CD38-077

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Toxin

Mechanisms of ActionLymphocyte differentiation antigen CD38 modulators

TargetsLymphocyte differentiation antigen CD38

Therapy Area/IndicationsMultiple MyelomaBurkitt Lymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesConcortis Biotherapeutics

China Registration ClassN/A

Develop Information

Active CompaniesConcortis Biotherapeutics

Inactive CompaniesN/A

Active IndicationsMultiple MyelomaBurkitt Lymphoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A